T1	Treatment 0 26	Fadrozole HCL (CGS-16949A)
T2	Treatment 34 51	megestrol acetate
T3	Treatment 391 404	fadrozole HCL
T4	Treatment 675 855	randomized to receive either fadrozole HCL, 1 mg twice daily, or megestrol acetate, 40 mg 4 times daily, in a double blind fashion after progression on first-line hormonal therapy.
T5	Treatment 1646 1659	Fadrozole HCL
T6	Treatment 1953 1966	fadrozole HCL
